These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 7632028

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Kwok S, Selby PL, McElduff P, Laing I, Mackness B, Mackness MI, Prais H, Morgan J, Yates AP, Durrington PN, Sci FM.
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):760-7. PubMed ID: 15579192
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Hormonal supplements for postmenopausal women: no evidence of protection against cardiovascular disease].
    Stehouwer CD.
    Ned Tijdschr Geneeskd; 2001 Jan 13; 145(2):61-4. PubMed ID: 11225257
    [Abstract] [Full Text] [Related]

  • 9. [Hormone replacement therapy and cardiovascular risk in menopausal women].
    Simon T, Jaillon P.
    Arch Mal Coeur Vaiss; 2001 Feb 13; 94(2):132-8. PubMed ID: 11265551
    [Abstract] [Full Text] [Related]

  • 10. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B, Icin T, Kovacev N.
    Med Pregl; 2009 Feb 13; 62 Suppl 3():85-90. PubMed ID: 19702123
    [Abstract] [Full Text] [Related]

  • 11. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M.
    J Insur Med; 1996 Feb 13; 28(1):27-34. PubMed ID: 10172866
    [Abstract] [Full Text] [Related]

  • 12. [Hormone replacement therapy and cardiovascular pathology in menopause].
    Micheli S, Marcucci R, Farsi A, Abbate R.
    Ann Ital Med Int; 1998 Feb 13; 13(1):37-46. PubMed ID: 9642841
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Postmenopausal hormone replacement therapy and cardiovascular disease.
    Chae CU, Ridker PM, Manson JE.
    Thromb Haemost; 1997 Jul 13; 78(1):770-80. PubMed ID: 9198254
    [Abstract] [Full Text] [Related]

  • 17. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
    Motolese M.
    Ital Heart J Suppl; 2003 Jul 13; 4(7):545-58. PubMed ID: 14558283
    [Abstract] [Full Text] [Related]

  • 18. [Quantitative evaluation of the cardiovascular risk associated with hormone substitution therapy during menopause].
    Scarabin PY, Plu-Bureau G.
    Arch Mal Coeur Vaiss; 1993 Feb 13; 86(2):243-8. PubMed ID: 8363427
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.